• Lipid Scrambling Regulates Ferroptosis and Tumor Immune Reje

  2026-06-27

  Yang et al. reveal TMEM16F-mediated lipid scrambling as a crucial regulator of ferroptosis, demonstrating that its inhibition sensitizes tumor cells to cell death and potentiates immune rejection. These findings clarify executional events at the plasma membrane during ferroptosis and suggest new strategies for cancer immunotherapy.

• Palonosetron Hydrochloride: Advances in CINV Prevention for

  2026-06-26

  Ruhlmann and Herrstedt's study evaluates palonosetron hydrochloride, a next-generation 5-HT3 receptor antagonist, for the prevention of chemotherapy-induced nausea and vomiting (CINV). Their review highlights palonosetron’s unique pharmacological properties and its clinical advantages in both acute and delayed CINV, offering actionable insights for optimizing supportive care in oncology.

• AZD0156: ATM Kinase Inhibitor Workflows for Cancer Research

  2026-06-26

  AZD0156 stands out as a potent and selective ATM kinase inhibitor, enabling researchers to precisely dissect DNA damage response and metabolic adaptation in cancer models. This guide translates the latest mechanistic insights into actionable, stepwise protocols and troubleshooting strategies for maximizing the value of AZD0156 in lab workflows.

• Redox Modulation and Osteoclastogenesis: Advanced Applicatio

  2026-06-25

  (S)-1-(3-fluoro-4-(trifluoromethoxy)phenyl)-3-(1-(2-methylbutanoyl)piperidin-4-yl)urea (BPN-19186) is transforming research into redox signaling and bone homeostasis. This article uniquely explores how new mechanistic insights and high-purity APExBIO reagents can shape innovative, translational study design.

• Optimizing Protein Extraction with Protease Inhibitor Cockta

  2026-06-25

  APExBIO’s Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO) delivers robust protection against proteolytic degradation during sensitive protein workflows, particularly where phosphorylation states and divalent cation integrity are mission-critical. Discover how to tailor protocols, troubleshoot, and maximize reproducibility with this advanced serine protease inhibitor blend.

• Palonosetron Hydrochloride: Advancing CINV Prevention in Che

  2026-06-24

  This article analyzes the clinical and mechanistic advances of palonosetron hydrochloride as a 5-HT3 receptor antagonist for chemotherapy-induced nausea and vomiting (CINV). Key findings reveal the unique pharmacologic properties of palonosetron and its impact on both acute and delayed CINV, with implications for optimizing supportive care in cancer chemotherapy.

• E. coli Uracil-DNA Glycosylase (UDG): Technical Use & Protoc

  2026-06-23

  E. coli Uracil-DNA Glycosylase (UDG) is used to excise uracil from DNA, aiding in the prevention of PCR product contamination and supporting DNA repair research. It is not suitable for RNA substrates, short oligonucleotides, or diagnostic applications.

• Betacoronaviruses Exploit ER Stress Pathways for Replication

  2026-06-23

  This study reveals distinct strategies by which MERS-CoV, HCoV-OC43, and SARS-CoV-2 manipulate the integrated stress response (ISR) and endoplasmic reticulum (ER) stress pathways in lung-derived cells to optimize viral protein synthesis and replication. The findings illuminate differential viral dependencies on eIF2α dephosphorylation, with implications for host-targeted antiviral strategies and ER stress research.

• THZ1: Covalent CDK7 Inhibitor Workflows in T-ALL Research

  2026-06-22

  THZ1 stands out as a covalent CDK7 inhibitor with nanomolar potency and unique selectivity for transcriptional regulation in cancer biology. This guide translates bench research and reference study insights into actionable protocols, troubleshooting strategies, and advanced applications for T-ALL and beyond.

• GKT137831: Dual NADPH Oxidase Nox1/Nox4 Inhibitor in Redox R

  2026-06-22

  GKT137831 empowers oxidative stress researchers with targeted, reproducible inhibition of Nox1 and Nox4, yielding precise control over ROS pathways in disease models. Its robust solubility and validated protocols streamline both cell-based and in vivo studies, advancing applications from vascular remodeling to fibrosis.

• Isoliensinine Modulates MAPK/NF-κB to Attenuate Neuroinflamm

  2026-06-21

  This study demonstrates that isoliensinine significantly reduces LPS-induced neuroinflammation in microglia by inhibiting the MAPK/NF-κB signaling pathway and mitigating oxidative stress and mitochondrial dysfunction. The findings provide mechanistic insights relevant for Alzheimer’s research and highlight actionable targets for neuroprotection.

• PEGylation Improves Targeted mRNA Delivery Stability and Eff

  2026-06-20

  Folda et al. demonstrate that PEGylation of LAF–xenopeptide mRNA polyplexes enhances colloidal stability and enables ligand-directed targeting without compromising biosafety. Their work clarifies how PEG content and surface functionalization can optimize mRNA delivery systems for therapeutic and research applications.

• Lipid Peroxidation (MDA) Assay Kit: Precision in Ferroptosis

  2026-06-19

  Discover how the Lipid Peroxidation (MDA) Assay Kit enables robust quantification of malondialdehyde, a key biomarker of oxidative stress, and uniquely advances mechanistic studies of ferroptosis and autophagy. This in-depth article explores assay design, protocol optimization, and translational value for advanced biomedical research.

• VX-661 and Calnexin: Precision CFTR Rescue for Translational

  2026-06-19

  This thought-leadership article explores the mechanistic and strategic landscape of VX-661 (F508del CFTR corrector) in cystic fibrosis research, focusing on the interplay between calnexin-dependent proteostasis and pharmacological rescue. Drawing on recent deep mutational scanning studies, it provides actionable insights for translational researchers aiming to optimize experimental workflows and personalize CFTR modulator strategies. The discussion goes beyond standard product guides, highlighting emerging challenges and future directions in the field.

• Carvedilol in β-Adrenergic Receptor Research: Applied Workfl

  2026-06-18

  Leverage Carvedilol’s unique dual antagonism and antioxidant properties for cutting-edge β-adrenergic and α1-adrenergic receptor research. This guide delivers actionable workflows, troubleshooting strategies, and data-driven insights to refine your cardiovascular, vascular, and hematopoietic assays.

16709 records 1/1114 page Next 12345 下5页 Last page